When a Virus Strikes Without a Cure: Why America Needs Real Global Health Investment
A Bundibugyo Ebola outbreak in the DRC has killed over 500 with no proven treatments. Clinical trials are underway, but this reveals a deeper problem: we don't invest in health until people are dying.
July 8, 2026 · Source: NPR
Over 50 days into an Ebola outbreak in the Democratic Republic of Congo and Uganda, more than 500 people are dead and 1,560 are sick. The virus responsible, Bundibugyo, is a rarer strain than the Zaire variant that's dominated previous outbreaks, which means there's no off-the-shelf treatment waiting on a shelf.
Clinicians are improvising. The World Health Organization announced that clinical trials have begun testing two existing drugs, remdesivir (an antiviral) and MBP-134 (a monoclonal antibody cocktail), hoping that treatments designed for something else might work. Other trials will test whether MBP-134 can prevent infection in exposed people. It's a reasonable triage approach. It's also a band-aid on a wound that shouldn't exist.
Why This Matters for America
The obvious reason is pandemic risk. Viruses don't respect borders. But there's a deeper principle: a country as wealthy as ours has no excuse for leaving global health capacity underfunded until bodies pile up and we panic-fund a crisis response.
This isn't about charity. It's about the architecture of survival. When the research infrastructure isn't there in advance, when scientists haven't already studied a virus, when pharmaceutical companies don't have standing relationships with health systems in outbreak zones, when clinical trial protocols have to be built from scratch during an active emergency, people die who don't have to.
The real lesson from every recent outbreak is what Dr. Amanda Rojek from the University of Oxford says plainly: "Research needs to happen alongside the response, not after it." That means funding. It means investing in global surveillance networks. It means maintaining research capacity even in years when nothing catastrophic is happening.
America has the wealth to do this. What we lack isn't money. It's the will to treat health as foundational, not just for Americans, but for the world we live in, because what spreads there spreads everywhere.